139 related articles for article (PubMed ID: 30076954)
1. Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism.
Li Y; Wang D; Lu S; Zeng L; Wang Y; Song W; Liu J
Eur J Pharm Sci; 2018 Nov; 124():80-88. PubMed ID: 30076954
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane.
Saepang K; Li SK; Chantasart D
Pharm Res; 2021 Apr; 38(4):657-668. PubMed ID: 33826056
[TBL] [Abstract][Full Text] [Related]
3. Nile red nanosuspensions as investigative model to study the follicular targeting of drug nanocrystals.
Corrias F; Schlich M; Sinico C; Pireddu R; Valenti D; Fadda AM; Marceddu S; Lai F
Int J Pharm; 2017 May; 524(1-2):1-8. PubMed ID: 28336458
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid based nanocrystals hydrogels for enhanced topical delivery of drug: A case study.
Wei S; Xie J; Luo Y; Ma Y; Tang S; Yue P; Yang M
Carbohydr Polym; 2018 Dec; 202():64-71. PubMed ID: 30287044
[TBL] [Abstract][Full Text] [Related]
5. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
[TBL] [Abstract][Full Text] [Related]
6. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
Elgindy NA; Mehanna MM; Mohyeldin SM
Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
10. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
11. Potential of transdermal drug delivery in Parkinson's disease.
Pfeiffer RF
Drugs Aging; 2002; 19(8):561-70. PubMed ID: 12207550
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity.
Raj R; Wairkar S; Sridhar V; Gaud R
Int J Biol Macromol; 2018 Apr; 109():27-35. PubMed ID: 29247729
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of dopamine receptor agonists.
Reichmann H
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S93-6. PubMed ID: 20123566
[TBL] [Abstract][Full Text] [Related]
15. Appraisal of Transdermal Water-in-Oil Nanoemulgel of Selegiline HCl for the Effective Management of Parkinson's Disease: Pharmacodynamic, Pharmacokinetic, and Biochemical Investigations.
Setya S; Madaan T; Tariq M; Razdan BK; Talegaonkar S
AAPS PharmSciTech; 2018 Feb; 19(2):573-589. PubMed ID: 28875405
[TBL] [Abstract][Full Text] [Related]
16. Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation.
Azeem A; Talegaonkar S; Negi LM; Ahmad FJ; Khar RK; Iqbal Z
Int J Pharm; 2012 Jan; 422(1-2):436-44. PubMed ID: 22057087
[TBL] [Abstract][Full Text] [Related]
17. Skin permeation of curcumin nanocrystals: Effect of particle size, delivery vehicles, and permeation enhancer.
Xiang H; Xu S; Zhang W; Li Y; Zhou Y; Miao X
Colloids Surf B Biointerfaces; 2023 Apr; 224():113203. PubMed ID: 36791520
[TBL] [Abstract][Full Text] [Related]
18. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation.
Pu T; Li X; Sun Y; Ding X; Pan Y; Wang Q
AAPS PharmSciTech; 2017 Apr; 18(3):738-748. PubMed ID: 27245330
[TBL] [Abstract][Full Text] [Related]
19. Study of magnetic silk fibroin nanoparticles for massage-like transdermal drug delivery.
Chen AZ; Chen LQ; Wang SB; Wang YQ; Zha JZ
Int J Nanomedicine; 2015; 10():4639-51. PubMed ID: 26229467
[TBL] [Abstract][Full Text] [Related]
20. Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules.
Li YZ; Quan YS; Zang L; Jin MN; Kamiyama F; Katsumi H; Tsutsumi S; Yamamoto A
J Pharm Pharmacol; 2009 Aug; 61(8):1005-12. PubMed ID: 19703343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
